Home › Funds › Siren, L.L.C. › ERAS
Siren, L.L.C. position in ERAS
Erasca, Inc. · Health Care
Siren, L.L.C. reported holding 13,197,781 shares of ERAS (Erasca, Inc.) in its Q3 2026 13F filing — a position valued at US$193.5M, representing 4.60% of its reported portfolio and ranking #3 among its reported holdings. Siren, L.L.C. has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s ERAS position evolved
Siren, L.L.C. first disclosed a stake in ERAS in Q3 2024 at 8,857,179 shares (US$24.2M). The position peaked in Q2 2026 at 11,397,781 shares, worth US$208.8M. Across 9 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 13,197,781 shares valued at US$193.5M — an increase of 1,800,000 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 8.86M | $24.18M | New |
| Q4 2024 | 8.86M | $22.23M | Hold |
| Q1 2025 | 8.76M | $12.00M | Reduce |
| Q2 2025 | 8.76M | $11.12M | Hold |
| Q3 2025 | 8.76M | $19.09M | Hold |
| Q4 2025 | 8.76M | $32.58M | Hold |
| Q1 2026 | 11.24M | $181.93M | Add |
| Q2 2026 | 11.40M | $208.81M | Add |
| Q3 2026 | 13.20M | $193.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (Erasca, Inc.) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 17.95M sh · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Logos Global Management LP 12.15M sh · $222.59M · Q2 2026
- Paradigm Biocapital Advisors LP 9.55M sh · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.25M sh · $96.18M · Q2 2026
- Vivo Capital, LLC 4.13M sh · $75.61M · Q2 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M sh · $41.35M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held ERAS?
Siren, L.L.C. has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in ERAS?
As of Q3 2026, Siren, L.L.C. holds 13.20M shares of ERAS (Erasca, Inc.), valued at $193.48M, representing 4.60% of its reported portfolio and ranking #3.
Has Siren, L.L.C. been buying or selling ERAS?
In the latest 13F filing (Q3 2026), Siren, L.L.C. increased its position in ERAS. The position peaked in Q2 2026 at 11.40M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.